Pim1 kinase synergizes with c-MYC to induce advanced prostate carcinoma
Open Access
- 8 February 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 29 (17), 2477-2487
- https://doi.org/10.1038/onc.2010.10
Abstract
The oncogenic PIM1 kinase has been implicated as a cofactor for c-MYC in prostate carcinogenesis. In this study, we show that in human prostate tumors, coexpression of c-MYC and PIM1 is associated with higher Gleason grades. Using a tissue recombination model coupled with lentiviral-mediated gene transfer we find that Pim1 is weakly oncogenic in naive adult mouse prostatic epithelium. However, it cooperates dramatically with c-MYC to induce prostate cancer within 6-weeks. Importantly, c-MYC/Pim1 synergy is critically dependent on Pim1 kinase activity. c-MYC/Pim1 tumors showed increased levels of the active serine-62 (S62) phosphorylated form of c-MYC. Grafts expressing a phosphomimetic c-MYCS62D mutant had higher rates of proliferation than grafts expressing wild type c-MYC but did not form tumors like c-MYC/Pim1 grafts, indicating that Pim1 cooperativity with c-MYC in vivo involves additional mechanisms other than enhancement of c-MYC activity by S62 phosphorylation. c-MYC/Pim1-induced prostate carcinomas show evidence of neuroendocrine (NE) differentiation. Additional studies, including the identification of tumor cells coexpressing androgen receptor and NE cell markers synaptophysin and Ascl1 suggested that NE tumors arose from adenocarcinoma cells through transdifferentiation. These results directly show functional cooperativity between c-MYC and PIM1 in prostate tumorigenesis in vivo and support efforts for targeting PIM1 in prostate cancer.Keywords
This publication has 46 references indexed in Scilit:
- Interactions between Cells with Distinct Mutations in c-MYC and Pten in Prostate CancerPLoS Genetics, 2009
- Shared TP53 gene mutation in morphologically and phenotypically distinct concurrent primary small cell neuroendocrine carcinoma and adenocarcinoma of the prostateThe Prostate, 2009
- A Role for Polyploidy in the Tumorigenicity of Pim-1-Expressing Human Prostate and Mammary Epithelial CellsPLOS ONE, 2008
- Pro-neural transcription factors as cancer markersBMC Medical Genomics, 2008
- Pim kinase-dependent inhibition of c-Myc degradationOncogene, 2008
- PIM1-dependent phosphorylation of histone H3 at serine 10 is required for MYC-dependent transcriptional activation and oncogenic transformationNature, 2007
- Genetic analysis of neuroendocrine tumor cells in prostatic carcinomaThe Prostate, 2005
- Pim‐1 kinase promotes inactivation of the pro‐apoptotic Bad protein by phosphorylating it on the Ser112 gatekeeper siteFEBS Letters, 2004
- Interleukin-6- and Cyclic AMP-Mediated Signaling Potentiates Neuroendocrine Differentiation of LNCaP Prostate Tumor CellsMolecular and Cellular Biology, 2001
- Delineation of prognostic biomarkers in prostate cancerNature, 2001